Pancreatic Cancer Medications
Definition of Pancreatic Cancer: Pancreatic carcinoma is a malignancy (cancer) of the pancreas.
Drugs (by generic name) associated with Pancreatic Cancer
The following drugs and medications are in some way related to, or used in the treatment of Pancreatic Cancer. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Pancreatic Cancer Medications in the Pipeline
- June 13, 2005 - U.S. FDA Agrees to Rolling New Drug Application for Virulizin
- January 3, 2005 - SuperGen Announces Withdrawal of Orathecin NDA
- November 29, 2004 - SuperGen Announces 90 Day Extension of FDA Review Date for Orathecin New Drug Application
- March 26, 2004 - SuperGen’s New Drug Application for Orathecin (rubitecan) capsules accepted by FDA for filing
- March 26, 2004 - SuperGen’s New Drug Application for Orathecin (rubitecan) capsules accepted by FDA for filing
- January 28, 2004 - SuperGen completes submission of New Drug Application (NDA) for Orathecin as an oral treatment for pancreatic cancer
Latest Pancreatic Cancer Blog Post
Sutent Significantly Improved Progression-Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors
New Data from a Phase 3 Trial Presented
NEW YORK--(BUSINESS WIRE)--Jun 25, 2009 - Pfizer today announced results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic islet cell tumors, also known as pancreatic...
View all Pancreatic Cancer blog posts.
Pancreatic Cancer Support Group Questions
Go to the Pancreatic Cancer support group or view all Pancreatic Cancer questions.
